Literature DB >> 30950085

Evaluation of a Multifaceted Intervention to Reduce Health Disparities in Hepatitis C Screening: A Pre-Post Analysis.

Mamta K Jain1,2, Nicole E Rich1,2, Chul Ahn3, Barbara J Turner4, Joanne M Sanders3, Brian Adamson3, Lisa Quirk3, Patrice Perryman3, Noel O Santini1,2, Amit G Singal1,2,3.   

Abstract

Hepatitis C virus (HCV) testing in persons born from 1945 to 1965 has had limited adoption despite guidelines, particularly among racial/ethnic minorities and socioeconomically disadvantaged patients, who have a higher prevalence of disease burden. We examined the effectiveness of a multifaceted intervention to improve HCV screening in a large safety-net health system. We performed a multifaceted intervention that included provider and patient education, an electronic medical record-enabled best practice alert, and increased HCV treatment capacity. We characterized HCV screening completion before and after the intervention. To identify correlates of HCV screening, we performed logistic regression for the preintervention and postintervention groups and used a generalized linear mixed model for patients observed in both preintervention and postintervention time frames. Before the intervention, 10.1% of 48,755 eligible baby boomer patients were screened. After the intervention, 34.6% of the 34,093 eligible baby boomers were screened (P < 0.0001). Prior to the intervention, HCV screening was lower among older baby boomers and providers with large patient panels and higher in high-risk subgroups including those with signs of liver disease (e.g., elevated transaminases, thrombocytopenia), human immunodeficiency virus-positive patients, and homeless patients. Postintervention, we observed increased screening uptake in older baby boomers, providers with larger patient panel size, and patients with more than one prior primary care appointment.
Conclusion: Our multifaceted intervention significantly increased HCV screening, particularly among older patients, those engaged in primary care, and providers with large patient panels.
© 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2019        PMID: 30950085     DOI: 10.1002/hep.30638

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Reply to MacDonald et al.

Authors:  Eshan U Patel; Shruti H Mehta; Denali Boon; Thomas C Quinn; David L Thomas; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

Review 2.  Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

Authors:  Andrew M Moon; Amit G Singal; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-08       Impact factor: 11.382

Review 3.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Robin Kate Kelley; Augusto Villanueva; Amit G Singal; Eli Pikarsky; Sasan Roayaie; Riccardo Lencioni; Kazuhiko Koike; Jessica Zucman-Rossi; Richard S Finn
Journal:  Nat Rev Dis Primers       Date:  2021-01-21       Impact factor: 52.329

4.  Increasing Hepatitis C Screening in a Federally Qualified Health Center: A Quality Improvement Initiative.

Authors:  Melissa D Klein; Bryna J Harrington; Joan East; Jennifer Cunningham; Nicole Ifill; Jan Lee Santos
Journal:  J Healthc Qual       Date:  2021 Sep-Oct 01       Impact factor: 1.095

Review 5.  Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.

Authors:  Allison E Wang; Eric Hsieh; Barbara J Turner; Norah Terrault
Journal:  J Gen Intern Med       Date:  2022-04-28       Impact factor: 6.473

6.  Patient and provider-level barriers to hepatitis C screening and linkage to care: A mixed-methods evaluation.

Authors:  Robin T Higashi; Mamta K Jain; Lisa Quirk; Nicole E Rich; Akbar K Waljee; Barbara J Turner; Simon Craddock Lee; Amit G Singal
Journal:  J Viral Hepat       Date:  2020-03-02       Impact factor: 3.728

7.  External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.

Authors:  Thierry Poynard; Jean Marc Lacombe; Olivier Deckmyn; Valentina Peta; Sepideh Akhavan; Victor de Ledinghen; Fabien Zoulim; Didier Samuel; Philippe Mathurin; Vlad Ratziu; Dominique Thabut; Chantal Housset; Hélène Fontaine; Stanislas Pol; Fabrice Carrat
Journal:  JHEP Rep       Date:  2021-04-24

8.  Micro-Elimination of Hepatitis C among Patients with Kidney Disease by Using Electronic Reminder System-A Hospital-Based Experience.

Authors:  Pei-Yuan Su; Wei-Wen Su; Yu-Chun Hsu; Shu-Yi Wang; Ping-Fang Chiu; Hsu-Heng Yen
Journal:  J Clin Med       Date:  2022-01-14       Impact factor: 4.241

Review 9.  Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review.

Authors:  Van C Willis; Kelly Jean Thomas Craig; Yalda Jabbarpour; Elisabeth L Scheufele; Yull E Arriaga; Monica Ajinkya; Kyu B Rhee; Andrew Bazemore
Journal:  JMIR Med Inform       Date:  2022-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.